ALTONasdaqIndustrial Organic ChemicalsFiscal year ends December 31
Alto Ingredients, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$3.49+0.04 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $268.98M
- P/E (TTM)
- 5.3
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
3.8%−2.1 pts over 5 years
Operating margin
0.8%−0.3 pts over 5 years
Net margin
1.5%+3.1 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -4.9% | -11.8% | +0.5% | -2.6% | |
| Gross profit | +259.1% | – | -8.0% | +12.9% | |
| Operating income | – | – | -5.7% | – | |
| Free cash flow | – | – | -33.2% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 0.4% | -5.8% | 5.7% | |
| Return on assets | 0.2% | -2.8% | 3.4% | |
| Current ratio | 2.98 | 2.46 | 2.64 | |
| Debt to equity | 0.51 | 0.33 | 0.32 | |
| Net debt to EBITDA | 2.28× | – | 1.73× | |
| Interest coverage | 1.0× | 0.5× | 0.7× | |
| Inventory turnover | 26.0× | 17.1× | 15.8× | |
| Capex to revenue | 1.2% | 0.7% | 0.5% | |
| Diluted shares | 0M | 0M | 76M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Alto Ingredients generated $71.66M from operations and spent $104.32M on capital expenditure, dividends and share buybacks. 95% of that went back into the business.
Generated
$71.66M
Used
$104.32M
Capital expenditure$99.32M95%Dividends$00%Share buybacks$5.00M5%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin1.5%
×Asset turnover2.32×
×Equity multiplier1.68×
=Return on equity, FY20255.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 1.5% | 2.32× | 1.68× | 5.7% |
| FY2024 | -6.1% | 2.26× | 1.70× | -23.4% |
| FY2023 | -2.3% | 2.62× | 1.59× | -9.5% |
| FY2022 | -3.1% | 2.77× | 1.47× | -12.7% |
| FY2021 | 3.8% | 2.51× | 1.50× | 14.4% |
| FY2020 | -1.7% | 1.65× | 2.08× | -5.8% |
| FY2019 | -6.2% | 2.24× | 2.33× | -32.6% |
| FY2018 | -4.0% | 2.20× | 2.04× | -17.8% |
| FY2017 | -2.1% | 2.29× | 1.92× | -9.4% |
| FY2016 | 0.1% | 2.35× | 1.82× | 0.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
6of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$13.34M
- Cash generatingOperating cash flow above zero$13.25M
- Return on assets improvedROA up on the prior year-13.0% → 3.3%
- Earnings backed by cashOperating cash flow above net income$13.25M vs $13.34M
- Less leverageLong-term debt to assets fell23.1% → 16.2%
- Better liquidityCurrent ratio rose2.65 → 2.64
- No dilutionShare count did not rise73M → 76M
- Gross margin improvedGross margin up on the prior year1.01% → 3.80%
- More efficientAsset turnover rose2.12 → 2.29